BIM
IMGN

Bogle Investment Management’s Immunogen Inc IMGN Stock Holding History

Bogle Investment Management’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-272,592
Closed -$2.87M – 370
2018
Q1 		$2.87M Buy
+272,592
New +$2.69M 0.22% 126
2015
Q4 		– Sell
-488,819
Closed -$4.69M – 454
2015
Q3 		$4.69M Sell
488,819
-362,719
-43% -$5.3M 0.33% 107
2015
Q2 		$12.2M Buy
+851,538
New +$9.35M 0.91% 16
2015
Q1 		– Sell
-771,842
Closed -$4.71M – 429
2014
Q4 		$4.71M Buy
+771,842
New +$7.06M 0.31% 110

Other funds holding IMGN

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bogle Investment Management's IMGN Position: Q2 2018 in Review

Bogle Investment Management sold out of Immunogen Inc (IMGN) in Q2 2018, closing a stake of 272,592 shares — an estimated $2.87M sold.

Bogle Investment Management first reported a position in IMGN in Q4 2014 and held it in 4 quarters. The position peaked at $12.2M in Q2 2015. 198 funds tracked by Wall St. Rank hold IMGN as of Q2 2018.

  • Bogle Investment Management reported no remaining Immunogen Inc position as of Q2 2018 after selling out during the quarter.
  • Bogle Investment Management sold 272,592 Immunogen Inc shares in Q2 2018, an estimated $2.87M.
  • Bogle Investment Management first reported a position in Immunogen Inc in Q4 2014 and held it in 4 quarters.
  • Bogle Investment Management's Immunogen Inc position peaked at $12.2M in Q2 2015.
  • 198 funds tracked by Wall St. Rank held Immunogen Inc as of Q2 2018.

Based on Bogle Investment Management's 13F filing for Q2 2018, filed 13 Aug 2018.